Author

Abiola Ibraheem

University of chicago - Cited by 348 - Cancer

Biography

Abiola Ibraheem, belonging to Department of Hematology and Oncology, University Chicago, Chicago, IL 60637, USA. Interested in the field of Autologous stem cell transplantation, Health disparity.
Title
Cited by
Year
Prospective international randomized phase II study of low-dose abiraterone with food versus standard dose abiraterone in castration-resistant prostate cancer
RZ Szmulewitz, CJ Peer, A Ibraheem, E Martinez, MF Kozloff, B Carthon, ...Journal of Clinical Oncology 36 (14), 1389, 2018201
150
2018
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
DJ Press, A Ibraheem, ME Dolan, KH Goss, S Conzen, D HuoBreast cancer research and treatment 168, 207-220, 2018201
28
2018
Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: who benefits from chemotherapy?
AF Ibraheem, DJ Press, OI Olopade, D HuoCancer 125 (2), 213-222, 2019201
28
2019
Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base
A Ibraheem, OI Olopade, D HuoCancer 126 (17), 4013-40, 2020202
22
2020
Improving the accrual of racial and ethnic minority patients in clinical trials: time to raise the stakes
A Ibraheem, B PoliteCancer 123 (24), 4752-4756, 171
20
2017
Infrastructural challenges lead to delay of curative radiotherapy in Nigeria
J Leng, AI Ntekim, A Ibraheem, CP Anakwenze, DW Golden, OI OlopadeJCO global oncology 6, 269-276,
20
2020
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes
F Zhao, B Copley, Q Niu, F Liu, JA Johnson, T Sutton, G Khramtsova, ...Breast cancer research and treatment 185, 841-849, 2021202
19
2021
Referral patterns and clinical outcomes for transplant-eligible lymphoma and myeloma patients evaluated at an urban county hospital
HD Yun, T Dossul, L Bernal-Mizrachi, J Switchenko, C Ndibe, A Ibraheem, ...Journal of stem cell research & therapy 6, 2016201
9
2016
Implementing oncology clinical trials in Nigeria: a model for capacity building
A Ntekim, A Ibraheem, A Adeniyi-Sofoluwe, T Adepoju, M Oluwasanu, ...BMC Health Services Research 20, 1-9, 2020202
8
2020
Formal assessment of teamwork among cancer health care professionals in three large tertiary centers in Nigeria
AF Ibraheem, M Giurcanu, AC Sowunmi, O Awolude, M Habeebu, ...JCO Global Oncology 6, 560-568, 2020202
7
2020
Cancer clinical trials in Africa—an untapped opportunity: recommendations from AORTIC 2019 conference special interest group in clinical trials
A Ibraheem, C Pillai, I Okoye, JJ Smith, D Reidy-Lagunes, G Macaulay, ...JCO Global Oncology 7, 1358-133, 2021202
6
2021
Chemotherapy-induced cardiotoxicity in breast cancer patients
A Ibraheem, TJ Stankowski-Drengler, OB Gbolahan, JM Engel, AA OnitiloBreast Cancer Management 5 (1), 31-41, 20120
6
2016
A prospective international randomized phase II study evaluating the food effect on the pharmacokinetics (PK) and pharmacodynamics (PD) of abiraterone acetate (AA) in men with …
RZ Szmulewitz, AF Ibraheem, CJ Peer, WD Figg, BC Carthon, M Kozloff, ...Journal of Clinical Oncology 35 (_suppl), 17-17, 2017201
6
2017
ARETTA: Assessing response to neoadjuvant taxotere and subcutaneous trastuzumab in Nigerian women with HER2-positive breast cancer: A study protocol
AI Ntekim, A Ibraheem, AA Sofoluwe, O Kotila, C Babalola, T Karrison, ...JCO global oncology 6, 983-990, 2020202
5
2020
Community clinical practice patterns and mortality in patients with Oncotype DX intermediate score: who benefits from chemotherapy?
AF Ibraheem, DJ Press, OI Olopade, D HuoCancer 125 (2), 21, 2019201
3
2019
SIRFLOX: progression-free survival in the liver as a surrogate end point for survival?
AO Ayoola, AF IbraheemJ Clin Oncol 34 (34), 4193, 01601
2
2016
Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer
KF Hoskins, GS Calip, HC Huang, A Ibraheem, OC Danciu, GH RauscherJAMA oncology 9 (4), 536-545, 030
2
2023
Survey of medical student knowledge in oncology and survivorship care in Nigeria: A pilot study.
J Leng, AF Ibraheem, AI Ntekim, A Popoola, L Agaga, E Ukoh, ...Journal of Clinical Oncology 37 (5_suppl), e806-e806, 20920
1
2019
Attitudes of breast cancer patients and oncology staff towards randomized clinical trials in southwest Nigeria.
J Leng, AF Ibraheem, AC Sowunmi, AF Ademola, A Ntekim, OI OlopadeJournal of Clinical Oncology 36 (5_suppl), e8663-e8663, 20820
1
2018
Comparison of public-private partnership and federally sponsored radiotherapy facilities in Nigeria
CP Anakwenze, S Grover, A Ibraheem, AH Klopp, A Jhingran, LL Lin, ...International Journal of Radiation Oncology, Biology, Physics 08 (3), e43-e44, 2020202
1
2020

Referred From: https://scholar.google.com/citations?user=tIwI6d8AAAAJ&hl=en

Cited by
Citations 348
h-index 8
i10-index 7
Recommended Journals
Open Access Journals